RxDoctor Payments DataLook up a doctor →

Stephen Henry, MD

Geriatric Medicine · Pasadena, CANPI 1811925183

Payments from drug & device makers

$25,242in general payments, 2019–2025

Across 1,132 payments — averaging $22.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$4K
  • AbbVie$3K
  • Viiv Healthcare Company$2K
  • Amgen$2K
  • Gilead$1K
  • Bausch Health US, LLC$1K
  • plus $12K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Johnson & Johnson(2 entities)92$4,110
AbbVie(2 entities)142$2,872
Viiv Healthcare Company89$1,818
Amgen(2 entities)92$1,678
Gilead68$1,431
Bausch Health US, LLC85$1,282
Novo Nordisk67$1,244
Otsuka America Pharmaceutical, Inc.40$819
Pfizer43$771
Takeda Pharmaceuticals U.S.A., Inc.32$600
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC30$532
Antares Pharma, Inc.28$512
GSK19$468
Novartis22$461
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)22$454
Lilly USA, LLC21$453
Lundbeck LLC16$431
Axsome Therapeutics, Inc.16$423
Regeneron Healthcare Solutions, Inc.15$385
Merck14$324
Esperion Therapeutics, Inc.14$318
Sanofi-aventis U.S. LLC7$315
Astellas Pharma US Inc13$232
Idorsia Pharmaceuticals US Inc10$189
Sanofi5$189
AstraZeneca9$177
Watermark Medical, Inc.1$157
Octapharma USA, Inc.5$149
Avadel CNS Pharmaceuticals, LLC5$129
Alkermes, Inc.6$125
Abbott6$123
Jazz Pharmaceuticals Inc.5$117
Eisai Inc.6$109
Vanda Pharmaceuticals Inc.3$105
Theratechnologies Inc.5$97
Akcea Therapeutics, Inc.4$92
Boehringer Ingelheim4$89
Alfasigma USA, Inc.4$89
Arbor Pharmaceuticals, Inc.4$84
Amarin Pharma, Inc.4$83
Currax Pharmaceuticals LLC5$78
Napo Pharmaceuticals Inc3$73
Lexicon Pharmaceuticals, Inc.2$66
Harmony Biosciences LLC2$65
Kowa Pharmaceuticals America, Inc.3$53
Bayer3$53
Biogen2$49
Clarus Therapeutics Inc.3$47
Alnylam Pharmaceuticals Inc.2$43
Nalpropion Pharmaceuticals LLC2$42
Supernus Pharmaceuticals, Inc.2$40
Shire North American Group Inc2$37
Amryt Pharma Holdings Ltd1$35
E.r. Squibb & Sons, L.L.C.2$34
Tolmar, Inc.2$31
Redhill Biopharma Inc.2$30
Nestle Healthcare Nutrition Inc.1$28
Boston Scientific1$27
Aimmune Therapeutics, Inc.1$26
Avanir Pharmaceuticals, Inc.1$25

How this compares

$25,242 in reported general payments places this provider in the 95th percentile of 494 geriatric medicine providers in California.

See all geriatric medicine providers in California →

Medicare billing

Part B allowed, 2024
$1,338,155
Medicare patients
605
Services billed
130,871

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other geriatric medicine in Pasadena

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →